Reliability and Validity of a Digital Version of a Structured Interview for Children and Adolescents (Kinder-eDIPS)

Reliability, Validity and Acceptance of the Kinder-eDIPS (Diagnostisches Interview Bei Psychischen Störungen im Kindes- Und Jugendalter)

The Kinder-eDIPS is a digital version of the Kinder-DIPS (Diagnostisches Interview bei Psychischen Störungen im Kindes- und Jugendalter), a structured interview to assess a variety of the most frequent psychological disorders in children and adolescents. In this study, the reliability, validity and acceptance of the Kinder-eDIPS will be tested in both a clinical and a non-clinical sample.

Study Overview

• Status: Completed
• Conditions: Psychological Disease
• Intervention / Treatment: Diagnostic test: Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter, digitale Version (Kinder-eDIPS)

Detailed Description

The Kinder-eDIPS is a digital version of the Kinder-DIPS (Diagnostisches Interview bei Psychischen Störungen im Kindes- und Jugendalter), a structured interview to assess a variety of the most frequent psychological disorders in children and adolescents. The interview is administered by trained clinicians with children/adolescents and one of their primary carers. The reliability, validity and acceptance of former versions of the Kinder-DIPS (Kinder-DIPS for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders) and DSM-III) have been studied. The aim of the present study is to test the reliability, validity and acceptance of the newly developed digital version of the Kinder-DIPS, the Kinder-eDIPS, in both a clinical and a non-clinical sample.

• Study Type: Observational
• Enrollment (Actual): 205

Contacts and Locations

Study Locations

• Germany
  • North-Rhine Westphalia
    • Bochum, North-Rhine Westphalia, Germany, 44780
      • Ruhr-University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

All families with children in the according age group who are willing to complete the structured interview and the questionnaires of the online-survey are allowed to take part in the study.

Description

Inclusion Criteria:

• sufficient knowledge of the German language

Exclusion Criteria:

-

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Clinical sample; Participants will be recruited from families in Bochum who receive treatment or wait for the treatment to begin at the Forschungs- und Behandlungszentrum (FBZ; outpatient treatment center).	Diagnostic test: Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter, digitale Version (Kinder-eDIPS); The Kinder-eDIPS is a digital, structured interviews which assesses the most frequent psychological disorders. It exists in a parent and a child version. It can be delivered by trained clinicians and takes between 60 and 120 minutes.
Nonclinical sample; Participants will be recruited from families in Bochum who take part in experiments and studies at the Department of Clinical Child and Adolescent Psychology at the Ruhr-University. The Department of Clinical Child and Adolescent Psychology maintains a database of families interested in participating in research.	Diagnostic test: Diagnostisches Interview bei psychischen Störungen im Kindes- und Jugendalter, digitale Version (Kinder-eDIPS); The Kinder-eDIPS is a digital, structured interviews which assesses the most frequent psychological disorders. It exists in a parent and a child version. It can be delivered by trained clinicians and takes between 60 and 120 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Kinder-eDIPS	digital, structured interview for children, adolescents and their parents/primary carers	within 1 week of the other measures

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Strengths and Difficulties Questionnaire (SDQ)	Questionnaire assessing emotional symptoms,conduct problems, hyperactivity/inattention, peer relationship problems and prosocial behaviour in 4-17 year olds (child and parent version)	within 1 week of the other measures
Spence Children's Anxiety Scale (SCAS)	Questionnaire assessing anxiety symptoms in 7-17 year olds (child and parent version)	within 1 week of the other measures
Short Mood and Feelings Questionnaire (SMFQ)	Questionnaire assessing depressive symptomology in 6-17 year olds (child and parent version)	within 1 week of the other measures
Child and Adolescent Trauma Screening (CATS)	Questionnaire assessing potentially traumatic events and posttraumatic stress symptoms in 7-17 year olds (child and parent version)	within 1 week of the other measures
Short form of the Eating Disorder Examination-Questionnaire adapted for children (ChEDE-Q8)	Questionnaire assessing eating disorder psychopathology in 7-18 year olds (only child version)	within 1 week of the other measures

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Acceptance of the Interview	Questionnaire assessing children's/adolescent's and parent's perception of the interview	within 1 week of the other measures

Collaborators and Investigators

• Sponsor: Ruhr University of Bochum
• Investigators: Study Director: Silvia Schneider, Prof., Ruhr-University; Principal Investigator: Ruth von Brachel, Dr., Ruhr-University

Study record dates

Study Major Dates

• Study Start (Actual): December 3, 2021
• Primary Completion (Actual): May 6, 2024
• Study Completion (Actual): May 6, 2024

Study Registration Dates

• First Submitted: August 21, 2023
• First Submitted That Met QC Criteria: August 21, 2023
• First Posted (Actual): August 25, 2023

Study Record Updates

• Last Update Posted (Actual): June 6, 2025
• Last Update Submitted That Met QC Criteria: June 3, 2025
• Last Verified: June 1, 2025

More Information

Terms related to this study

• Keywords: children and adolescents; structured interview; psychological disease
• Other Study ID Numbers: 737

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No